Patent · US Active

Method for producing dabigatran etexilate methansulphonate

US9546154B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Michael Guenter Wohlgemuth · Ingelheim am Rhein, DE
Volker Brenk · Bingen, DE
Ingo Heddesheimer · Monzingen, DE
Bernhard Schmitz · Frankenthal (Pfalz), DE

Key dates

Filing date	Aug 6, 2015
Grant date	Jan 17, 2017
Priority date	—
Expiry date	Aug 6, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2021/8416
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

An improved method of preparing dabigatran etexilate mesylate (1-salt),is described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.